Coppell Advisory Solutions Expands Portfolio With Thermo Fisher and Visa Stakes

For Thermo Fisher Scientific, institutional ownership is reported at 89.23% of the shares, underscoring how widely held the stock is among funds and asset managers.
Texas Instruments’ filing coverage included specific balance-sheet liquidity and leverage metrics—quick ratio of 3.44, current ratio of 4.86, and debt-to-equity ratio of 0.72—along with an identified market valuation set (market cap of $232.70 billion).
Texas Instruments also disclosed a recent dividend detail: $1.42 per share paid August 11 (record date July 31), implying an annualized $5.68 dividend and a roughly 2.2% yield (as described in the article).
Visa coverage tied the investment backdrop to product updates: Visa launched an enhanced A2A Protect with “real-time risk insights” and a “unified fraud score” incorporating Featurespace technology, aimed at stopping account-to-account fraud before funds leave customer accounts.
The Visa article also highlighted an announced integration enabling payment cards to be linked to palm biometrics through an alliance with Handwave, positioning it as a step toward more secure and convenient tokenized/biometric payment transactions.
Coppell Advisory Solutions LLC has widened its bets across technology and healthcare, buying major stakes in Thermo Fisher Scientific and Texas Instruments during the second quarter. watchlistnews reports the investment firm purchased 813 shares of Thermo Fisher valued at roughly $408,000 and committed $5.3 million to acquire 17,765 Texas Instruments shares, signaling confidence in both the medical research and semiconductor sectors.
Coppell's new Thermo Fisher stake of 813 shares comes as institutional investors hold 89.23% of the company's outstanding shares. watchlistnews indicates the $408,000 purchase reflects confidence in the life sciences leader despite the crowded shareholder base. The entry size suggests Coppell is taking a measured position rather than a major bet.
Coppell's $5.3 million Texas Instruments purchase of 17,765 shares represents its largest single investment among the disclosed positions. watchlistnews notes the company boasts a strong balance sheet with a quick ratio of 3.44 and a current ratio of 4.86. Texas Instruments also paid a $1.42-per-share dividend on August 11, yielding roughly 2.2% annually on a $5.68 annualized payout.
Coppell acquired 6,445 Visa shares valued at $2.2 million as the payments giant rolls out upgraded fraud tools. watchlistnews reports Visa launched an enhanced A2A Protect platform with real-time risk insights and unified fraud scoring powered by Featurespace technology. The system targets account-to-account fraud before money leaves customer accounts, addressing a growing payment security concern.
Visa is also advancing biometric payments through a new partnership with Handwave, enabling payment cards linked to palm recognition. watchlistnews describes this as a step toward more secure tokenized transactions. The dual investment in fraud prevention and biometric security suggests Coppell sees Visa positioned to lead next-generation payment safety.
Beyond tech and payments, Coppell purchased 5,574 Xylem shares worth $659,000 to add industrial exposure. watchlistnews reports the investment rounds out a portfolio spanning medical research, semiconductors, payments, and industrials. Coppell also bought 297,893 shares of the First Trust Alternative Absolute Return Strategy ETF valued at $94,000, adding a diversified hedge strategy to complement its direct equity stakes.
Publishers
14
Articles
6
Reach
20